This review highlights the role of Angiotensin II as a growth regulator in the kidney, contributing to cellular hypertrophy and mitogenesis.
Answers are grounded in this paper and cite their sources.
Extends mechanistic insights on Ang II in renal growth; leaves open whether pathway modulation improves clinical outcomes.
Angiotensin II (AII) has many of the features of the archetypical growth factors and appears to be a growth regulator in the kidney. AII binds to specific cell surface receptors present on a number of different renal cell types including mesangial, vascular smooth muscle, tubular and interstitial cells, and activates many of the intracellular signalling pathways associated with cell growth. In vitro AII can potentiate the mitogenic effect of other growth factors such as EGF. AII induces hypertrophy of vascular smooth muscle cells but the role of AII in the growth of other renal cell types has not been systematically studied.
No takes yet. Share an insight, caveat, or question.
Jill T. Norman (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: